A180 DIN 02261200
Health Canada record
| Active ingredient(s) | DANOFLOXACIN (DANOFLOXACIN MESYLATE) 180 MG |
|---|---|
| Dosage form | Solution |
| Route | Subcutaneous |
| Schedule | PRESCRIPTION |
| Class | Veterinary |
| ATC | |
| Original market date | 10-Feb-2005 |
| Current status date | 07-Jan-2015 |
| Source | Health Canada DPD |
Establishment licence of the holder
Zoetis Canada Inc — licence 102076, currently licensed, last inspection rating C (2023-10-05).
No Canadian shortage report is currently matched to this DIN.
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 22050 | 2019-04-09 | Supplement to a New Drug Submission (SNDS) | ADDITION OF AN ALTERNATE DRUG MANUFACTURING AND TESTING SITE |
| 17609 | 2015-12-23 | Supplement to a New Drug Submission (SNDS) | ADDITIONAL CLAIM |
| 15247 | 2014-02-13 | New Drug Submission (NDS) | TRANSFER OF DRUG IDENTIFICATION HNUMBER (DIN) HOLDER |
| 9132 | 2007-10-24 | Supplement to a New Drug Submission (SNDS) | CHANGE IN MANUFACTURING SITE |
| 5919 | 2004-11-24 | New Drug Submission (NDS) |